Literature DB >> 25753553

Inter-observer reliability of the PASI in a clinical setting.

Samantha Cabrera1, Niranthari Chinniah, Nannette Lock, Geoffrey D Cains, Jane Woods.   

Abstract

BACKGROUND: With the evolving emphasis on evidence-based practice, the use of reliable clinical scales forms an important foundation for clinical assessment. The psoriasis area and severity index (PASI) is the most widely used tool for the measurement of psoriasis severity; however, there has been some debate over the potential reproducibility of PASI scoring.
OBJECTIVES: To determine the inter-observer reliability of the PASI at a large tertiary hospital with a psoriasis treatment centre.
METHODS: In total, 34 patients who were due for their 3-monthly follow up at a psoriasis treatment centre were independently evaluated by five clinical staff (observers) from the Department of Dermatology. Each observer independently determined the PASI score of each patient and the inter-observer reliability coefficient was determined by employing intra-class correlation coefficients (ICC).
RESULTS: There was a significant degree of concordance among the PASI scoring of observers (ICC = 0.804; CI 95%: 0.706-0.883).
CONCLUSIONS: Our cross-sectional study suggests that the PASI provides a reproducible method of assessing psoriasis severity among patients seen in a busy dermatology clinic at a large tertiary hospital.
© 2015 The Australasian College of Dermatologists.

Entities:  

Keywords:  ICC; PASI; PASI reliability; inter-observer reliability; interrater reliability; psoriasis; psoriasis area and severity index; psoriasis assessment; psoriasis severity; reliability

Mesh:

Year:  2015        PMID: 25753553     DOI: 10.1111/ajd.12280

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease.

Authors:  Aigar Ottas; Dmytro Fishman; Tiia-Linda Okas; Külli Kingo; Ursel Soomets
Journal:  Arch Dermatol Res       Date:  2017-07-10       Impact factor: 3.017

2.  Assessment and Clinical Relevance of Serum IL-19 Levels in Psoriasis and Atopic Dermatitis Using a Sensitive and Specific Novel Immunoassay.

Authors:  Robert J Konrad; Richard E Higgs; George H Rodgers; Wenyu Ming; Yue-Wei Qian; Nicoletta Bivi; Justin K Mack; Robert W Siegel; Brian J Nickoloff
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

3.  Follow-Up Comparison of Fluorescence Optical Imaging With Musculoskeletal Ultrasound for Early Detection of Psoriatic Arthritis.

Authors:  Juliane Büttner; Anne-Marie Glimm; Georgios Kokolakis; Magdalena Erdmann-Keding; Gerd-Rüdiger Burmester; Paula Hoff; Jens Klotsche; Sarah Ohrndorf
Journal:  Front Med (Lausanne)       Date:  2022-03-18

4.  Image-based automated Psoriasis Area Severity Index scoring by Convolutional Neural Networks.

Authors:  M J Schaap; N J Cardozo; A Patel; E M G J de Jong; B van Ginneken; M M B Seyger
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-18       Impact factor: 9.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.